These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 7931256

  • 1. Deamination of aliphatic amines by type B monoamine oxidase and semicarbazide-sensitive amine oxidase; pharmacological implications.
    Yu PH, Davis BA, Boulton AA, Zuo DM.
    J Neural Transm Suppl; 1994; 41():397-406. PubMed ID: 7931256
    [Abstract] [Full Text] [Related]

  • 2. Some pharmacological implications of MAO-mediated deamination of branched aliphatic amines: 2-propyl-1-aminopentane and N-(2-propylpentyl)glycinamide as valproic acid precursors.
    Yu PH, Davis BA.
    J Neural Transm Suppl; 1990; 32():89-92. PubMed ID: 2128515
    [Abstract] [Full Text] [Related]

  • 3. The deamination of n-pentylamine by monoamine oxidase and a semicarbazide-sensitive amine oxidase of rat heart.
    Guffroy C, Fowler CJ, Strolin Benedetti M.
    J Pharm Pharmacol; 1983 Jul; 35(7):416-20. PubMed ID: 6136581
    [Abstract] [Full Text] [Related]

  • 4. Semicarbazide-sensitive amine oxidase and monoamine oxidase in rat brain microvessels, meninges, retina and eye sclera.
    Zuo DM, Yu PH.
    Brain Res Bull; 1994 Jul; 33(3):307-11. PubMed ID: 8293314
    [Abstract] [Full Text] [Related]

  • 5. Properties of mammalian tissue-bound semicarbazide-sensitive amine oxidase: possible clues to its physiological function?
    Lyles GA.
    J Neural Transm Suppl; 1994 Jul; 41():387-96. PubMed ID: 7931255
    [Abstract] [Full Text] [Related]

  • 6. Deamination of 2-propyl-1-aminopentane and 2-[(2-propyl)pentylamino] acetamide by amine oxidases: formation of valproic acid.
    Yu PH, Davis BA.
    Prog Neuropsychopharmacol Biol Psychiatry; 1991 Jul; 15(2):303-6. PubMed ID: 1908106
    [Abstract] [Full Text] [Related]

  • 7. Several aspects on the amine oxidation by semicarbazide-sensitive amine oxidase (SSAO) from bovine lung.
    Lizcano JM, Fernandez de Arriba A, Lyles GA, Unzeta M.
    J Neural Transm Suppl; 1994 Jul; 41():415-20. PubMed ID: 7931259
    [Abstract] [Full Text] [Related]

  • 8. Deamination of methylamine by semicarbazide-sensitive amine oxidase in human umbilical artery and rat aorta.
    Precious E, Gunn CE, Lyles GA.
    Biochem Pharmacol; 1988 Feb 15; 37(4):707-13. PubMed ID: 3342102
    [Abstract] [Full Text] [Related]

  • 9. Substrate-specificity of mammalian tissue-bound semicarbazide-sensitive amine oxidase.
    Lyles GA.
    Prog Brain Res; 1995 Feb 15; 106():293-303. PubMed ID: 8584666
    [Abstract] [Full Text] [Related]

  • 10. Age-related changes in the activities of the amine metabolizing enzymes of rat eye.
    Cao Danh H, Strolin Benedetti M, Mousset A, Pasquier-Béchet P.
    J Pharm Pharmacol; 1985 May 15; 37(5):357-61. PubMed ID: 2862249
    [Abstract] [Full Text] [Related]

  • 11. Monoamine oxidase and semicarbazide-sensitive amine oxidase in spontaneously hypertensive and in normotensive control rats.
    Guffroy C, Strolin Benedetti M.
    Life Sci; 1984 Feb 06; 34(6):535-45. PubMed ID: 6694535
    [Abstract] [Full Text] [Related]

  • 12. Properties of a semicarbazide-sensitive amine oxidase in human umbilical artery.
    Precious E, Lyles GA.
    J Pharm Pharmacol; 1988 Sep 06; 40(9):627-33. PubMed ID: 2907029
    [Abstract] [Full Text] [Related]

  • 13. 2-propyl-1-aminopentane, its deamination by monoamine oxidase and semicarbazide-sensitive amine oxidase, conversion to valproic acid and behavioral effects.
    Yu PH, Davis BA.
    Neuropharmacology; 1991 May 06; 30(5):507-15. PubMed ID: 1865997
    [Abstract] [Full Text] [Related]

  • 14. Deamination of aliphatic amines of different chain lengths by rat liver monoamine oxidase A and B.
    Yu PH.
    J Pharm Pharmacol; 1989 Mar 06; 41(3):205-8. PubMed ID: 2568453
    [Abstract] [Full Text] [Related]

  • 15. Oxidative deamination of aliphatic amines by rat aorta semicarbazide-sensitive amine oxidase.
    Yu PH.
    J Pharm Pharmacol; 1990 Dec 06; 42(12):882-4. PubMed ID: 1983156
    [Abstract] [Full Text] [Related]

  • 16. Physiological and pathological implications of semicarbazide-sensitive amine oxidase.
    Yu PH, Wright S, Fan EH, Lun ZR, Gubisne-Harberle D.
    Biochim Biophys Acta; 2003 Apr 11; 1647(1-2):193-9. PubMed ID: 12686132
    [Abstract] [Full Text] [Related]

  • 17. The metabolism of aminoacetone to methylglyoxal by semicarbazide-sensitive amine oxidase in human umbilical artery.
    Lyles GA, Chalmers J.
    Biochem Pharmacol; 1992 Apr 01; 43(7):1409-14. PubMed ID: 1567465
    [Abstract] [Full Text] [Related]

  • 18. The oxidation of dopamine by the semicarbazide-sensitive amine oxidase (SSAO) from rat vas deferens.
    Lizcano JM, Balsa D, Tipton KF, Unzeta M.
    Biochem Pharmacol; 1991 Apr 15; 41(8):1107-10. PubMed ID: 2009089
    [Abstract] [Full Text] [Related]

  • 19. Some properties of monoamine oxidase and a semicarbazide sensitive amine oxidase capable of the deamination of 5-hydroxytryptamine from porcine dental pulp.
    Norqvist A, Oreland L, Fowler CJ.
    Biochem Pharmacol; 1982 Sep 01; 31(17):2739-44. PubMed ID: 7138570
    [Abstract] [Full Text] [Related]

  • 20. Semicarbazide-sensitive amine oxidases in sheep plasma: interactions with some substrates and inhibitors.
    Crosbie AE, Callingham BA.
    J Neural Transm Suppl; 1994 Sep 01; 41():427-32. PubMed ID: 7931261
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.